Review



allogeneic mscs  (AllCells LLC)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    AllCells LLC allogeneic mscs
    Allogeneic Mscs, supplied by AllCells LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogeneic mscs/product/AllCells LLC
    Average 90 stars, based on 1 article reviews
    allogeneic mscs - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    prochymal, an allogeneic msc(m) investigational product  (Osiris Therapeutics)
    90
    Osiris Therapeutics prochymal, an allogeneic msc(m) investigational product
    Prochymal, An Allogeneic Msc(M) Investigational Product, supplied by Osiris Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/prochymal, an allogeneic msc(m) investigational product/product/Osiris Therapeutics
    Average 90 stars, based on 1 article reviews
    prochymal, an allogeneic msc(m) investigational product - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    stempeucel's allogeneic bm-mscs product  (Stempeutics)
    90
    Stempeutics stempeucel's allogeneic bm-mscs product
    MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
    Stempeucel's Allogeneic Bm Mscs Product, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stempeucel's allogeneic bm-mscs product/product/Stempeutics
    Average 90 stars, based on 1 article reviews
    stempeucel's allogeneic bm-mscs product - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogeneic mscs of adipocyte origin darvadstrocel  (Takeda)
    90
    Takeda allogeneic mscs of adipocyte origin darvadstrocel
    MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
    Allogeneic Mscs Of Adipocyte Origin Darvadstrocel, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogeneic mscs of adipocyte origin darvadstrocel/product/Takeda
    Average 90 stars, based on 1 article reviews
    allogeneic mscs of adipocyte origin darvadstrocel - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogeneic bm-msc  (Stempeutics)
    90
    Stempeutics allogeneic bm-msc
    Main characteristics of the included clinical trials.
    Allogeneic Bm Msc, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogeneic bm-msc/product/Stempeutics
    Average 90 stars, based on 1 article reviews
    allogeneic bm-msc - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogenic bm-msc (25 × 10 6 cells) + vs  (Stempeutics)
    90
    Stempeutics allogenic bm-msc (25 × 10 6 cells) + vs
    Main characteristics of the included clinical trials.
    Allogenic Bm Msc (25 × 10 6 Cells) + Vs, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogenic bm-msc (25 × 10 6 cells) + vs/product/Stempeutics
    Average 90 stars, based on 1 article reviews
    allogenic bm-msc (25 × 10 6 cells) + vs - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogeneic mscs  (AllCells LLC)
    90
    AllCells LLC allogeneic mscs
    Main characteristics of the included clinical trials.
    Allogeneic Mscs, supplied by AllCells LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogeneic mscs/product/AllCells LLC
    Average 90 stars, based on 1 article reviews
    allogeneic mscs - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogeneic adipose mscs on hydrogel sheet deb topical phase 1/2 nct05157958  (Anterogen Co Ltd)
    90
    Anterogen Co Ltd allogeneic adipose mscs on hydrogel sheet deb topical phase 1/2 nct05157958
    Main characteristics of the included clinical trials.
    Allogeneic Adipose Mscs On Hydrogel Sheet Deb Topical Phase 1/2 Nct05157958, supplied by Anterogen Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogeneic adipose mscs on hydrogel sheet deb topical phase 1/2 nct05157958/product/Anterogen Co Ltd
    Average 90 stars, based on 1 article reviews
    allogeneic adipose mscs on hydrogel sheet deb topical phase 1/2 nct05157958 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogenic mscs therapy  (Cynata Therapeutics)
    90
    Cynata Therapeutics allogenic mscs therapy
    Cartilage-related clinical trials using <t> iPSC-MSCs </t> and chondrocytes
    Allogenic Mscs Therapy, supplied by Cynata Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogenic mscs therapy/product/Cynata Therapeutics
    Average 90 stars, based on 1 article reviews
    allogenic mscs therapy - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    allogenic mscs  (Bone Therapeutics)
    90
    Bone Therapeutics allogenic mscs
    Papers assessing the use of cell therapies in acute fracture care
    Allogenic Mscs, supplied by Bone Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/allogenic mscs/product/Bone Therapeutics
    Average 90 stars, based on 1 article reviews
    allogenic mscs - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

    Journal: Regenerative Therapy

    Article Title: Beyond conventional therapies: MSCs in the battle against nerve injury

    doi: 10.1016/j.reth.2024.12.017

    Figure Lengend Snippet: MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

    Article Snippet: An Indian company known as Stempeutics conducted a phase 4 clinical trial in September 2021, and the results indicated that Stempeucel's allogeneic BM-MSCs product was safe, effective, and had positive, long-lasting effects that not only reduced pain but aided in ulcer healing for severe limb ischemia triggered by Buerger's disease.

    Techniques: Clinical Proteomics, Transplantation Assay, Derivative Assay, Diffusion-based Assay, Imaging, Membrane, Cell Culture, Injection

    Main characteristics of the included clinical trials.

    Journal: Journal of Orthopaedic Translation

    Article Title: Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials

    doi: 10.1016/j.jot.2024.07.012

    Figure Lengend Snippet: Main characteristics of the included clinical trials.

    Article Snippet: 7 , Gupta 2016 [ ] , India , N = 60 Mean age between 54.00 ± 6.73 and 58.10 ± 8.2 years KL grade II-III KOA , Allogeneic BM-MSC (four groups with 5, 50, 75, or 150 × 10 6 cells) + VS N = 10 , Placebo N = 5 , Adverse events Serious adverse events VAS WOMAC ICOAP WORMS X-ray , Up to 2 years , Stempeutics Research Pvt. Ltd. Protocol registration reported (NCT01453738).

    Techniques: Comparison, Control

    Main characteristics of the included clinical trials.

    Journal: Journal of Orthopaedic Translation

    Article Title: Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials

    doi: 10.1016/j.jot.2024.07.012

    Figure Lengend Snippet: Main characteristics of the included clinical trials.

    Article Snippet: 8 , Gupta 2022 [ ] , India , N = 146 Mean age of 40–60 years KL grade II-III KOA , Allogenic BM-MSC (25 × 10 6 cells) + VS N = 73 , VS N = 73 , Adverse events Serious adverse events WOMAC VAS MRI , Up to 12 months , Stempeutics Research Pvt LtdProtocol registration reported (CTRI/2018/09/015785).

    Techniques: Comparison, Control

    Cartilage-related clinical trials using iPSC-MSCs and chondrocytes

    Journal: Stem Cell Research & Therapy

    Article Title: iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review

    doi: 10.1186/s13287-024-03794-1

    Figure Lengend Snippet: Cartilage-related clinical trials using iPSC-MSCs and chondrocytes

    Article Snippet: In 2020, the University of Sydney and Cynata Therapeutics conducted phase 1 clinical trial to evaluate the safety, efficacy, and cost-effectiveness of an allogenic MSCs therapy (Cymerus MSCs) for tibiofemoral knee OA [ ].

    Techniques: Clinical Proteomics, Injection

    Papers assessing the use of cell therapies in acute fracture care

    Journal: Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology

    Article Title: Cellular therapies for bone repair: current insights

    doi: 10.1186/s10195-024-00768-0

    Figure Lengend Snippet: Papers assessing the use of cell therapies in acute fracture care

    Article Snippet: Jayankura et al. 2021 [ ] , Percutaneous injection of allogenic MSCs into long-bone delayed union , Tibia—8 Humerus—5 Femur—3 Ulna—3 Fibula—2 Radius—1 , 6.6 months , Allogenic MSCs (ALLOB, Bone Therapeutics) , Nil Original fixation retained.

    Techniques: Injection, Cell Culture

    Papers assessing the use of cell therapy in nonunion

    Journal: Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology

    Article Title: Cellular therapies for bone repair: current insights

    doi: 10.1186/s10195-024-00768-0

    Figure Lengend Snippet: Papers assessing the use of cell therapy in nonunion

    Article Snippet: Jayankura et al. 2021 [ ] , Percutaneous injection of allogenic MSCs into long-bone delayed union , Tibia—8 Humerus—5 Femur—3 Ulna—3 Fibula—2 Radius—1 , 6.6 months , Allogenic MSCs (ALLOB, Bone Therapeutics) , Nil Original fixation retained.

    Techniques: Injection, Membrane

    Papers assessing the use of cell therapy in the management of bone defects

    Journal: Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology

    Article Title: Cellular therapies for bone repair: current insights

    doi: 10.1186/s10195-024-00768-0

    Figure Lengend Snippet: Papers assessing the use of cell therapy in the management of bone defects

    Article Snippet: Jayankura et al. 2021 [ ] , Percutaneous injection of allogenic MSCs into long-bone delayed union , Tibia—8 Humerus—5 Femur—3 Ulna—3 Fibula—2 Radius—1 , 6.6 months , Allogenic MSCs (ALLOB, Bone Therapeutics) , Nil Original fixation retained.

    Techniques: Injection, Blocking Assay

    Miscellaneous papers assessing the use of cell therapy

    Journal: Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology

    Article Title: Cellular therapies for bone repair: current insights

    doi: 10.1186/s10195-024-00768-0

    Figure Lengend Snippet: Miscellaneous papers assessing the use of cell therapy

    Article Snippet: Jayankura et al. 2021 [ ] , Percutaneous injection of allogenic MSCs into long-bone delayed union , Tibia—8 Humerus—5 Femur—3 Ulna—3 Fibula—2 Radius—1 , 6.6 months , Allogenic MSCs (ALLOB, Bone Therapeutics) , Nil Original fixation retained.

    Techniques: Injection